| I'd like to tell you about a change of address https://deliziaricevimenti.it/stmap_966d602.html?timolol.viagra.duphalac.acivir decadron pharmacy2us The 15-year survival data showed no significant difference between groups (HR 1.02, 95% CI 0.97-1.08). Stratified by cancer grade, the 10-year survival showed a slight but nonsignificant advantage for finasteride in men with low-grade prostate cancer and virtually no difference among men with high-grade disease.
|